Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapy for rare factor deficiencies.

J Di Paola1, D Nugent, G Young

  • 1Division of Hematology, Children's Hospital of Orange County, Orange, California 92868, USA.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|March 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time matric potential dynamics in peat casings amended with wood fibre and bark, and their relationship to Agaricus bisporus yield and quality.

Fungal biology·2025
Same author

Visualizing dynamics of charges and strings in (2 + 1)D lattice gauge theories.

Nature·2025
Same author

Scaling and logic in the colour code on a superconducting quantum processor.

Nature·2025
Same author

Thermalization and criticality on an analogue-digital quantum simulator.

Nature·2025
Same author

Phase transitions in random circuit sampling.

Nature·2024
Same author

Dynamics of magnetization at infinite temperature in a Heisenberg spin chain.

Science (New York, N.Y.)·2024
Same journal

Exploratory Claims-Based Assessment of Diagnosed and Potentially Undiagnosed von Willebrand Disease in Japan.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Use of an Oral Health-Related Quality of Life Instrument to Measure Unmet Dental Care Needs in Adults With Inherited Bleeding Disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross-Sectional Study of Patient- and Joint-Level Analyses Using Musculoskeletal Ultrasound.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Utilisation and Perceived Value of Genetic Counsellors Within US Haemophilia Treatment Centres.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Correction to "Reference Values for the Haemophilia Joint Health Score in Patients With Severe Haemophilia Derived From the Canadian Bleeding Disorder Registry".

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Monitoring of Coagulation Potential of Efanesoctocog Alfa in Haemophilia A: Insights From Conventional and Global Hemostasis Assays.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
See all related articles

Rare inherited bleeding disorders, excluding hemophilia and von Willebrand disease, involve deficiencies in various clotting factors. Treatment utilizes available purified factor concentrates or blood products tailored to the specific factor deficiency.

Area of Science:

  • Hematology
  • Coagulation Disorders
  • Blood Transfusion Medicine

Background:

  • Inherited bleeding disorders encompass hemophilia A, B, and von Willebrand disease (80-85%), with rarer deficiencies comprising the remaining 15%.
  • Acquired factor deficiencies can arise from diverse conditions, including malignancies and autoimmune disorders, presenting a wide spectrum of bleeding severity.
  • Diagnosis relies on identifying decreased activity of specific clotting factors.

Purpose of the Study:

  • To review the landscape of rare inherited and acquired clotting factor deficiencies.
  • To outline diagnostic approaches for these conditions.
  • To summarize current treatment strategies and available therapeutic products.

Main Methods:

  • Review of literature on inherited and acquired clotting factor deficiencies.

Related Experiment Videos

  • Analysis of diagnostic criteria based on clotting factor activity assays.
  • Compilation of available treatment options, including factor concentrates and blood products.

    • Main Results:

    • Rare factor deficiencies (fibrinogen, prothrombin, factors V, VII, X, XI, XIII) present with variable bleeding symptoms.
    • Limited availability of specific factor concentrates for rare deficiencies necessitates alternative treatments.
    • Treatment options include purified concentrates, prothrombin complex concentrates, cryoprecipitate, fresh frozen plasma, and recombinant factor VIIa.

    Conclusions:

    • Effective management of rare clotting factor deficiencies requires accurate diagnosis and appropriate use of available therapeutic agents.
    • The choice of treatment depends on the specific factor deficiency and its severity.
    • Continued research and development of factor-specific therapies are crucial for improving patient outcomes.